NEW GS-441524 FORMULATION: 55% more FIP treatment per vial

Updated: Jan 20


  1. To prevent avoidable deaths caused by under-dosage associated with 15mg/ml formulation, especially in non-effusive Dry FIP cases, when the gravity of the FIP infection is difficult to evaluate.

  2. To reduce relapses caused by prolonged under-dosage during a 12 week treatment.

  3. To combat neurological FIP cases that require stronger dosage to arrest aggressive viral replication in the central nervous system.

  4. To reduce the pain of injections in larger cats, when a greater amount of GS is needed.

  5. To make FIP treatment more affordable to a greater number of cat owners.